Safety and Efficacy of Selinexor Sequential Azacytidine in Newly Diagnosed Patients with Myelodysplastic Syndromes EB1 or EB2: A Single-Center, Single-Arm, Phase Ib/II Trial

被引：0
|
作者：
Ma, Liya [1 ]
Yang, Wenli [1 ]
Zhou, Xinping [1 ]
Ye, Li [1 ]
Xu, Gaixiang [1 ]
Hu, Chao [1 ]
Luo, Yingwan [1 ]
Yang, Chunmei [1 ]
Ge, Zheng [2 ]
Tong, Hongyan [3 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China
[2] Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-183101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Chi, Yihebali
    Ji, Guangqian
    Zhang, Jing
    Tang, Haijian
    Yang, Yang
    Liu, Wei
    Wang, Nan
    Gao, Chunhui
    Sun, Yongkun
    Wang, Jinwan
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (09) : 1611 - 1618
  • [2] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Yihebali Chi
    Guangqian Ji
    Jing Zhang
    Haijian Tang
    Yang Yang
    Wei Liu
    Nan Wang
    Chunhui Gao
    Yongkun Sun
    Jinwan Wang
    International Journal of Clinical Oncology, 2021, 26 : 1611 - 1618
  • [3] Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial
    Chen, Xiaoqin
    Wang, Yun
    Wang, Weida
    Wang, Hua
    Wu, Bingyi
    Liang, Yang
    Xia, Zhongjun
    BLOOD, 2024, 144 : 7025 - 7026
  • [4] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
    Lai, Shuzhen
    Li, Peijing
    Liu, Xiaohui
    Liu, Guihong
    Xie, Tieming
    Zhang, Xing
    Wang, Xiaoxuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Lu, Fangxiao
    Wang, Lei
    Jiang, Fagui
    Sun, Caixing
    Chen, Yuanyuan
    Chen, Ming
    CANCER BIOLOGY & MEDICINE, 2024, 21 (05)
  • [5] Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial
    Taylor, Justin
    Mi, Xiaoli
    Penson, Alexander, V
    Paffenholz, Stella, V
    Alvarez, Kelsey
    Sigler, Allison
    Chung, Stephen S.
    Rampal, Raajit K.
    Park, Jae H.
    Stein, Eytan M.
    Tallman, Martin S.
    Sen, Filiz
    Gonen, Mithat
    Abdel-Wahab, Omar
    Klimek, Virginia M.
    LANCET HAEMATOLOGY, 2020, 7 (08): : E566 - E574
  • [6] Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial
    Zhou, De
    Huang, Xianbo
    Li, Xueying
    Zhu, Lixia
    Xie, Mixue
    Huang, Xin
    Yu, Fang
    Wei, Juying
    Ma, Liya
    Yang, Xiudi
    Sun, Jianai
    Li, Li
    Xie, Wanzhuo
    Tong, Hongyan
    Jin, Jie
    Zhu, Honghu
    Ye, Xiujin
    BLOOD, 2022, 140 : 2620 - 2621
  • [7] How to Improve the Efficacy of Venetoclax and Azacitidine(VA)for Newly Diagnosed Acute Myeloid Leukemia?a Prospective, Single-Center, Single-Arm, Phase 2 Trial for New Diagnosed AML
    Li, Xuekai
    Li, Mengyun
    Cui, Wei
    Chen, Xiaoqian
    Yu, Yan
    Chen, Juan
    Zhang, Xin
    Cui, Qingya
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2024, 144 : 4284 - 4284
  • [8] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase Ⅱ trial
    Shuzhen Lai
    Peijing Li
    Xiaohui Liu
    Guihong Liu
    Tieming Xie
    Xing Zhang
    Xiaoxuan Wang
    Jing Huang
    Yiqiang Tang
    Zhigang Liu
    Guoping Shen
    Chaoming Li
    Fangxiao Lu
    Lei Wang
    Fagui Jiang
    Caixing Sun
    Yuanyuan Chen
    Ming Chen
    Cancer Biology & Medicine, 2024, 21 (05) : 433 - 444
  • [9] Efficacy and safety of apatinib in patients with recurrent uterine malignancy: a prospective, single-center, single-arm, phase 2 study
    Ren, Yulan
    Wang, Tingting
    Cheng, Xi
    Ke, Guihao
    Huang, Yan
    Yang, Huijuan
    Huang, Xiao
    Tian, Wenjuan
    Wang, Huaying
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [10] Neoadjuvant pamiparib in patients with newly diagnosed advanced ovarian cancer: A single-arm, prospective phase II trial
    Liu, Jing
    Hu, Dan
    Li, Li
    Zang, Lele
    Zhu, Fei
    Zhu, Mingxuan
    Zhang, Huiqi
    Chang, Lele
    Xu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345